DK115489A - Foerfoedselscreening for down's syndrom - Google Patents

Foerfoedselscreening for down's syndrom

Info

Publication number
DK115489A
DK115489A DK115489A DK115489A DK115489A DK 115489 A DK115489 A DK 115489A DK 115489 A DK115489 A DK 115489A DK 115489 A DK115489 A DK 115489A DK 115489 A DK115489 A DK 115489A
Authority
DK
Denmark
Prior art keywords
syndrome
alpha
dheas
hydroxy
dehydroepiandrosterone sulphate
Prior art date
Application number
DK115489A
Other languages
English (en)
Other versions
DK115489D0 (da
DK172477B1 (da
Inventor
Nicholas John Wald
Howard Stephen Cuckle
Jacob Abraham Canick
James Edward Haddow
Original Assignee
Research Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26292455&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK115489(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB878716158A external-priority patent/GB8716158D0/en
Priority claimed from GB878724913A external-priority patent/GB8724913D0/en
Application filed by Research Corp filed Critical Research Corp
Publication of DK115489D0 publication Critical patent/DK115489D0/da
Publication of DK115489A publication Critical patent/DK115489A/da
Application granted granted Critical
Publication of DK172477B1 publication Critical patent/DK172477B1/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743Steroid hormones
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/38Pediatrics
    • G01N2800/385Congenital anomalies
    • G01N2800/387Down syndrome; Trisomy 18; Trisomy 13

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Endocrinology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Holo Graphy (AREA)
DK198901154A 1987-07-09 1989-03-09 Fremgangsmåde til bestemmelse af risiko af Down's syndrom og analysemidler til anvendelse derved DK172477B1 (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB878716158A GB8716158D0 (en) 1987-07-09 1987-07-09 Antenatal screening for down's syndrome
GB8716158 1987-07-09
GB8724913 1987-10-23
GB878724913A GB8724913D0 (en) 1987-10-23 1987-10-23 Antenatal screening for down's syndrome
PCT/GB1988/000557 WO1989000696A1 (en) 1987-07-09 1988-07-11 Antenatal screening for down's syndrome
GB8800557 1988-07-11

Publications (3)

Publication Number Publication Date
DK115489D0 DK115489D0 (da) 1989-03-09
DK115489A true DK115489A (da) 1989-05-09
DK172477B1 DK172477B1 (da) 1998-09-14

Family

ID=26292455

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198901154A DK172477B1 (da) 1987-07-09 1989-03-09 Fremgangsmåde til bestemmelse af risiko af Down's syndrom og analysemidler til anvendelse derved

Country Status (6)

Country Link
EP (1) EP0362294B1 (da)
JP (1) JP2525474B2 (da)
AT (1) ATE91182T1 (da)
DE (1) DE3882140T2 (da)
DK (1) DK172477B1 (da)
WO (1) WO1989000696A1 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0666477B1 (en) * 1989-01-17 2003-10-15 JN Macri Technologies LLC, Inc. Apparatus for detecting Down syndrome by non-invasive maternal blood screening
US5252489A (en) * 1989-01-17 1993-10-12 Macri James N Down syndrome screening method utilizing dried blood samples
US5258907A (en) * 1989-01-17 1993-11-02 Macri James N Method and apparatus for detecting down syndrome by non-invasive maternal blood screening
US5324667A (en) * 1989-01-17 1994-06-28 Macri James N Method for detecting down sydrown by non-invasive maternal blood screening
GB9224965D0 (en) * 1992-11-28 1993-01-20 Kodak Ltd Antenatal screening for chromosomal abnormalities
GB9306354D0 (en) * 1993-03-26 1993-05-19 Kodak Ltd Antenatal screening for chromosomal abnormalities
GB9315230D0 (en) * 1993-07-22 1993-09-08 Kodak Ltd Antenatal screening for chromosomal abnormalities
US5583612A (en) * 1994-07-14 1996-12-10 Xerox Corporation Flexible latch with relaxed engagement
GB9416415D0 (en) * 1994-08-13 1994-10-05 Kodak Ltd Antenatel screening for pregnacy abnormalities
GB9606261D0 (en) * 1996-03-25 1996-05-29 Johnson & Johnson Clin Diag Prenatal screening for fetal abnormalities
KR100459271B1 (ko) * 2002-04-26 2004-12-03 엘지.필립스 엘시디 주식회사 구리 단일막 또는 구리 몰리브덴막의 식각용액 및 그식각방법
WO2012049874A1 (ja) * 2010-10-13 2012-04-19 ヒューマン・メタボローム・テクノロジーズ株式会社 脂肪性肝疾患を診断するためのバイオマーカー、その測定方法、コンピュータプログラム、および、記憶媒体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4454232A (en) * 1982-06-07 1984-06-12 Bio-Rad Laboratories, Inc. Estriol assay
GR850899B (da) * 1984-04-12 1985-11-25 Gen Hospital Corp
US4670401A (en) * 1985-01-25 1987-06-02 Monell Chemical Senses Center Axillary androstenol and dehydroepiandrosterone as fertile period onset indicators

Also Published As

Publication number Publication date
DE3882140T2 (de) 1993-12-23
EP0362294A1 (en) 1990-04-11
JPH03502483A (ja) 1991-06-06
JP2525474B2 (ja) 1996-08-21
DK115489D0 (da) 1989-03-09
ATE91182T1 (de) 1993-07-15
DE3882140D1 (en) 1993-08-05
WO1989000696A1 (en) 1989-01-26
EP0362294B1 (en) 1993-06-30
DK172477B1 (da) 1998-09-14

Similar Documents

Publication Publication Date Title
Tulppala et al. Polycystic ovaries and levels of gonadotrophins and androgens in recurrent miscarriage: prospective study in 50 women
Krantz et al. First-trimester Down syndrome screening using dried blood biochemistry and nuchal translucency
US7892774B2 (en) Diagnostic method for determining the susceptibility to delivery and reagent kit for use therefor
DK115489D0 (da) Foerfoedselscreening for down's syndrom
IL139302A0 (en) Antenatal screening for down's syndrome
EP0316919A3 (en) Vaginal sample test and reagents
ATE412896T1 (de) Pränatales down-syndrom-testverfahren unter benutzung von hyperglykosyliertem gonadotropin
IE44204L (en) Reagent for pregnancy testing
DK0409956T3 (da) Downs syndrom-screeningmetode
Dumps et al. Accuracy of single measurements of pregnancy-associated plasma protein-A, human chorionic gonadotropin and progesterone in the diagnosis of early pregnancy failure
ATE163971T1 (de) Verfahren zur isolierung von fetalen zytotrophoblastzellen
Houghton et al. Relationship of maternal and fetal levels of human placental lactogen to the weight and sex of the fetus
ATE227024T1 (de) Verfahren und vorrichtung zur feststellung des down-syndroms durch nichtinvasive analyse von mütterlichem blut
DE69525400D1 (de) Vorgeburtliche Überprüfung von Schwangerschaftsabnormitäten
Andersen Concentrations of free oestradiol and progesterone in human preovulatory follicular fluid
Loncar et al. Advent of maternal serum markers for Down syndrome screening
Johnson et al. The role of trophoblast dysfunction in the aetiology of miscarriage
Garau et al. Estrogen and progesterone receptor assays on the vulvar epithelium
Spencer Is the measurement of unconjugated oestriol of value in screening for Down’s syndrome
JP3440138B2 (ja) 染色体異常について妊娠期間中にスクリーニングするための方法および装置
Seki et al. Correlation between urinary oestrogen levels determined by haemagglutination inhibition reaction and serum oestradiol levels determined by radioimmunoassay
Chatzakis et al. Dramatic increase in levels of placental protein 14 in amniotic fluid at 10–15 weeks' pregnancy
AHMED et al. Determination of the stage of gestation by the assay of chorionic gonadotrophin and Schwangerschaftsprotein 1
Grudzinskas Biochemical screening for down syndrome: A workshop report
UA41203A (uk) Спосіб прогнозування невиношування вагітності в ранніх термінах

Legal Events

Date Code Title Description
PUP Patent expired